Videa achieves landmark FDA clearance for 30+ dental conditions: here’s what you need to know
January 4, 2024
Videa recently announced a groundbreaking achievement—Videa Dental AI (VDA), making it the largest FDA clearance in dental AI and the first in pediatric dental AI. This milestone isn't just significant for Videa; it's a pivotal moment in dentistry, carrying profound implications for dental technology advancement and patient care on a broader scale.
Securing FDA clearance highlights Videa’s rigorous adherence to stringent regulatory standards, affirming its safety, effectiveness, and reliability. This milestone marks a watershed moment, paving the way for future advancements in AI-driven dental technology and instilling confidence in practitioners and patients regarding Videa's transformative potential and credibility within the broader healthcare landscape.
What is the new FDA clearance?
Videa Dental AI (VDA) is a collection of AI models on Videa cleared by the FDA that is made up of 30+ dental detections. With the addition of these dental detections, Videa redefines AI in dentistry by offering extensive pathology detection suites covering major treatments like caries, periodontal concerns, and endodontic lesions. Additionally, Videa introduces the world's first dental pediatric AI for patients aged three and up, providing unmatched precision and consistency in annotations for pediatric cases and offering insights into subtle diseases across all age groups.
Validated by dental experts, VDA features millions of annotations by 100+ clinical experts, resulting in improved pathology detection by 100% of dentists across various pathologies.
What is included in this new FDA clearance?
VDA covers many dental detections that will make their way into the Videa platform. Some of those dental detections include potential:
- Carious lesion detection on ALL primary and secondary teeth: Providers can use Videa to help diagnose al patients 3 years and older.
- Carious lesion detection on periapical x-rays: providers can diagnose potential caries on all teeth, particularly anterior teeth, using PAs.
- Periapical radiolucency detection or PRL: Providers to use Videa to more effectively identify signs of infection, monitor the progress of apex concerns, or identify cysts.
- Calculus detection: providers can use Videa to educate patients and influence the treatment and need for Scaling and Root Planing or other periodontal procedures. This, combined with our Radiographic Bone Level model, paints a picture of disease prognosis for the patient and the clinician.
- Existing restorative concerns: With Videa, providers can better differentiate caries from existing restorative concerns, like open margins.
- Other concerns like furcation, widened PDL, attrition, broken and chipped teeth, pulp stones, and dens invaginatus: providers can use Videa beyond periodontal and caries diagnosis.
To see the complete FDA clearance, click here.
Understanding FDA Clearance and Its Significance
FDA clearance is a regulatory milestone indicating that a product has undergone evaluation and approval for a specific use within the FDA's guidelines. For medical devices and technologies, this clearance ensures safety, efficacy, and quality, meeting the necessary standards for clinical use.
Videa's clearance encompasses a sophisticated artificial intelligence system to analyze medical imaging or aid dental providers in diagnosis and treatment planning. Such advancements can streamline processes, enhance accuracy, and improve patient outcomes.
The FDA confirmed Videa Dental AI, granting clearance for 10 clinical pathologies and 25 dental detections, securing the largest AI FDA clearance in radiology/x-ray. This achievement is a testament to Videa’s dedication to quality and innovation.
Impact and Implications of FDA Clearance
The impact of FDA clearance from Videa extends beyond the company itself, significantly benefitting healthcare providers, practitioners, and patients. Providers gain access to cutting-edge technology to augment their decision-making processes, leading to more accurate diagnoses and personalized treatments. Videa plays a role in early detection, empowering dentists to identify small lesions across patients and image types, simplifying treatments, and enhancing patient care.
Patients can anticipate improved dental healthcare experiences. Earlier and more precise diagnoses could mean faster treatment initiation, potentially leading to better prognoses and overall outcomes. Ultimately, FDA clearance for innovative technologies like those developed by Videa sets a higher standard for patient care and signifies a leap forward in healthcare innovation.
Why FDA Clearance Matters
FDA clearance is more than a stamp of approval; it symbolizes a commitment to ensuring the safety and effectiveness of medical technologies. The rigorous evaluation processes these innovations undergo fosters trust among healthcare providers and patients, setting high standards for quality.
One standout with this clearance is Videa's commitment to making the most sensitive AI on the market. The importance of catching things early and making the most comprehensive AI was important enough to Videa that they improved the original caries model, ensuring world-class AI.
Moreover, this clearance opens doors for further advancements and collaborations in the dental space. It encourages investment and innovation, leading to continuous improvement and the development of more groundbreaking solutions to address dentistry challenges.
Videa's attainment of FDA clearance is a significant achievement in dental technology, representing a step forward in harnessing AI's power to revolutionize patient care and medical diagnostics.
How can you get involved?
No matter your role in a dental practice or DSO, you can instantly discover the benefits of Videa. Videa has proven to be easy to onboard and get going quickly. There’s no better time than the present to see what AI can do for you.
For more information on Videa and how Videa can help your practice or Dental Service Organization, schedule a time to meet with one of our team members.
Related blog posts

Jan 21, 2026
Dental insurance verification: the complete guide to faster, cleaner eligibility checks and better collections
.png)
Jun 3, 2025
Why top dental schools trust Videa to elevate education and care
Discover why leading dental schools trust Videa’s FDA-cleared AI to boost diagnostics, student training, and patient communication.
%2520copy.png)
Nov 24, 2025
3 Real-World outcomes from Videa: insights from leading DSOs
As dental AI adoption accelerates, DSOs are increasingly focused on understanding the real impact these technologies deliver inside their organizations. Recent insights from P1 Dental Partners and Gen4 Dental Partners highlight how AI is moving beyond small pilots and becoming an essential component of modern clinical and operational strategy. By deploying AI across their networks, these DSOs reported meaningful improvements in diagnostic clarity, treatment communication, case acceptance, and day-to-day workflow efficiency. Their experiences demonstrate how AI can support clinicians, strengthen patient trust, and create scalable systems that help multi-location organizations maintain quality and consistency as they grow.
Get started today
Schedule time with our team to learn more.
